Skip to main content
. 2004 Aug;58(2):134–141. doi: 10.1111/j.1365-2125.2004.02105.x

Table 3c.

c.Moderate asthma

Dose (µg) 10 20 100 200 800 Within-day change
sGaw 28.8* 46.8* 68.5* 82.5* 100.9* 9.0
(7.6, 50) (17.4, 76.2) (28.5, 109) (33.5, 131.5) (38.4, 163.4) (−4.5, 22.5)
R5 11.4* 17.3* 26.3* 30* 30.8* −0.1
(5.4, 17.4) (10.2, 24.4) (19.2, 33.4) (22.3, 37.7) (21.9, 39.7) (−10.2, 10)
R20 5.1 8.9 16.1* 16.3* 21* 3.4
(−1.1, 11.3) (2.3, 15.5) (10.6, 21.6) (7.5, 25.1) (15.2, 26.8) (−2.8, 9.6)
X5 21* 31.7* 39.1* 41.5* 42* −1.6
(14.4, 27.6) (22.1, 41.3) (29, 49.2) (30.1, 52.9) (29.5, 54.5) (−11.9, 8.7)
RF 17.3* 23.7* 33.5* 36* 37.2* 1.5
(9.2, 25.4) (15.8, 31.6) (25.1, 41.9) (25.1, 46.9) (26.8, 47.6) (−8.6, 11.6)
FEV1 9.7* 16.9* 25.3* 28.1* 32.5* 0.9
(1.4, 18) (6.3, 27.5) (9.9, 40.7) (11.7, 44.5) (13.5, 51.5) (−1.7, 3.5)
MMEF 12.5* 25.4* 36.5* 45.6* 52.8* −0.3
(0.8, 24.2) (9, 41.8) (20.2, 52.8) (25.2, 66) (23.9, 81.7) (−4.3, 3.7)
*

p 0.05 denotes dose at which significant change compared with variability occurred. Data are mean percentage change (95% confidence interval).